Considering Pharmaceutical Rebates

JAMA Intern Med. 2018 Aug 1;178(8):1139-1140. doi: 10.1001/jamainternmed.2018.3044.
No abstract available

Publication types

  • Comment

MeSH terms

  • Atorvastatin
  • Drug Costs*
  • Drugs, Generic
  • Health Expenditures*

Substances

  • Drugs, Generic
  • Atorvastatin